Younossi ZM - Search Results

1

Type 2 diabetes and the minor allele of PNPLA3 consistently identify high-risk metabolic dysfunction associated steatotic liver disease.

Younossi ZM, Estep JM, Felix S, Lam B, Younossi Z, Racila A, Stepanova M. Younossi ZM, et al. Diabetes Res Clin Pract. 2025 Jan;219:111960. doi: 10.1016/j.diabres.2024.111960. Epub 2024 Dec 13. Diabetes Res Clin Pract. 2025. PMID: 39675485

2

Nonalcoholic fatty liver disease in patients with type 2 diabetes.

Younossi ZM, Gramlich T, Matteoni CA, Boparai N, McCullough AJ. Younossi ZM, et al. Clin Gastroenterol Hepatol. 2004 Mar;2(3):262-5. doi: 10.1016/s1542-3565(04)00014-x. Clin Gastroenterol Hepatol. 2004. PMID: 15017611

3

A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).

Younossi ZM, Jarrar M, Nugent C, Randhawa M, Afendy M, Stepanova M, Rafiq N, Goodman Z, Chandhoke V, Baranova A. Younossi ZM, et al. Obes Surg. 2008 Nov;18(11):1430-7. doi: 10.1007/s11695-008-9506-y. Epub 2008 May 24. Obes Surg. 2008. PMID: 18500507

4

Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon-alfa and ribavirin.

Younossi ZM, Baranova A, Afendy A, Collantes R, Stepanova M, Manyam G, Bakshi A, Sigua CL, Chan JP, Iverson AA, Santini CD, Chang SY. Younossi ZM, et al. Hepatology. 2009 Mar;49(3):763-74. doi: 10.1002/hep.22729. Hepatology. 2009. PMID: 19140155

5

Expression of cytokine signaling genes in morbidly obese patients with non-alcoholic steatohepatitis and hepatic fibrosis.

Estep JM, Baranova A, Hossain N, Elariny H, Ankrah K, Afendy A, Chandhoke V, Younossi ZM. Estep JM, et al. Among authors: younossi zm. Obes Surg. 2009 May;19(5):617-24. doi: 10.1007/s11695-009-9814-x. Epub 2009 Mar 12. Obes Surg. 2009. PMID: 19280268

6

Treatment regimens for non-alcoholic fatty liver disease.

Lam BP, Younossi ZM. Lam BP, et al. Among authors: younossi zm. Ann Hepatol. 2009;8 Suppl 1:S51-9. Ann Hepatol. 2009. PMID: 19381125 Free article. Review.

7

Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.

Younossi ZM, Afendy A, Stepanova M, Hossain N, Younossi I, Ankrah K, Gramlich T, Baranova A. Younossi ZM, et al. Among authors: younossi i. Liver Int. 2009 Oct;29(9):1403-12. doi: 10.1111/j.1478-3231.2009.02060.x. Epub 2009 Jun 3. Liver Int. 2009. PMID: 19515216

8

Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease.

Hossain N, Afendy A, Stepanova M, Nader F, Srishord M, Rafiq N, Goodman Z, Younossi Z. Hossain N, et al. Clin Gastroenterol Hepatol. 2009 Nov;7(11):1224-9, 1229.e1-2. doi: 10.1016/j.cgh.2009.06.007. Epub 2009 Jun 25. Clin Gastroenterol Hepatol. 2009. PMID: 19559819

9

Hepatic stellate cell and myofibroblast-like cell gene expression in the explanted cirrhotic livers of patients undergoing liver transplantation.

Estep JM, O'Reilly L, Grant G, Piper J, Jonsson J, Afendy A, Chandhoke V, Younossi ZM. Estep JM, et al. Among authors: younossi zm. Dig Dis Sci. 2010 Feb;55(2):496-504. doi: 10.1007/s10620-009-0919-9. Epub 2009 Aug 13. Dig Dis Sci. 2010. PMID: 19680808

10

Hepatic gene expression of Caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease.

Stepanova M, Hossain N, Afendy A, Perry K, Goodman ZD, Baranova A, Younossi Z. Stepanova M, et al. Obes Surg. 2010 May;20(5):640-50. doi: 10.1007/s11695-010-0078-2. Epub 2010 Jan 30. Obes Surg. 2010. PMID: 20119733

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

619 results

Search Page

Filters